Author name: Anna

Innovation and Patient Advocacy at the World Conference on Lung Cancer 2025 in Barcelona September 18, 2025 Barcelona, September 6–9, 2025 — The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) proudly participated in the World Conference on Lung Cancer for the first time. This conference offered a valuable opportunity to learn about the latest developments […]

Rising Tide Foundation for Clinical Cancer Research Continues Partnership with Blood Cancer United to Co-Fund ACT Grants September 12, 2025 Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is pleased to continue its collaboration with Blood Cancer United in co-funding Academic Clinical Trials (ACT) initiative – an investigator-initiated clinical trial program designed to address unmet

Grantee Spotlight: SAKK 01/18 Trial Drives Change in Global Cancer Guidelines August 7, 2025 We’re proud to share a major milestone achieved by one of our completed grants: the “SAKK 01/18 trial: Reduced intensity radio-chemotherapy for stage IIA/B seminoma” has led to a significant update in the National Comprehensive Cancer Network (NCCN) guidelines (image 1). Led by Dr.

RTFCCR and KCA Launch Joint Call for Proposals on Early Detection of Kidney Cancer June 5, 2025 The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and the Kidney Cancer Association (KCA) are proud to announce a new joint Request for Applications (RFA) to advance the early detection and diagnosis of kidney cancer.  This collaborative

RTFCCR Team Visits Gustave Roussy  May 27, 2025 At the end of April, the Rising Tide Foundation’s for Clinical Cancer Research (RTFCCR) team travelled to Paris, France to visit their grantee, Institute Gustave Roussy, one of the world’s top research institutes and the leading oncological hospital in Europe.  RTFCCR is excited to be supporting four

RTFCCR Presence at the St.Gallen International Breast Cancer Conference 2025 in Vienna, Austria  April 24, 2025 Earlier this month, Alexandre Alencar and Zoraide Granchi from the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) team attended the 19th St. Gallen International Breast Cancer Conference in Vienna. At the conference, Alexandre and Zoraide had an opportunity